Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the safety, metabolism, and antioxidant activity
of silymarin and green tea extract are changed when they are given in combination to patients
with chronic hepatitis C infection.
Phase:
Phase 1
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborators:
National Center for Complementary and Integrative Health (NCCIH) National Institutes of Health (NIH)